[E-Daily Reporter Shin Ha-yeon ] BL Pharmtech(065170)announced on the 13th that it has decided to acquire 727,272 shares of KwangdongHealthbio worth 1,047,270,000 won. This represents 10.55% of the company’s equity.
Following the acquisition, the company will hold 1,770,958 shares, representing a 13.96% stake. The shares will be acquired with cash, and the purpose of the acquisition is to strengthen business cooperation between the two companies—including the launch of new products—through the acquisition of an additional stake.
Following the acquisition, the company will hold 1,770,958 shares, representing a 13.96% stake. The shares will be acquired with cash, and the purpose of the acquisition is to strengthen business cooperation between the two companies—including the launch of new products—through the acquisition of an additional stake.
